Upwork Unveils Most In-Demand Work Skills in 2024
SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) — Upwork (Nasdaq: UPWK), the world’s work marketplace that connects businesses with […]
Sprout Social Launches New Mentorship Network for Marketers
CHICAGO, March 19, 2024 (GLOBE NEWSWIRE) — Sprout Social, an industry-leading provider of cloud-based social media management software, today announced […]
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
LEXINGTON, Mass., March 19, 2024 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection […]
Hudson Announces Change of Name to AnorTech Inc.
VANCOUVER, British Columbia, March 19, 2024 (GLOBE NEWSWIRE) — HUDSON RESOURCES INC. (“Hudson” or the “Company”) (TSX Venture Exchange “HUD”; […]
Lowell Farms to Announce Fourth Quarter and Fiscal Year 2023 Financial and Operational Results
SALINAS, Calif., March 19, 2024 (GLOBE NEWSWIRE) — Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF), a California-born cannabis company with advanced production capabilities […]
Urbana Corporation Has Filed Audited 2023 Annual Financial Statements
/NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./ TORONTO, March 19, 2024 (GLOBE NEWSWIRE) — Urbana […]
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for February 2024
Total Revenue up 141% Y/Y from February last year February Self-Mining Business Revenue up 159% Y/Y and up 23% M/M, […]
SELLAS Life Sciences to Host Corporate Update Call on March 26, 2024, at 8:15 am ET
– Update on the Phase 3 REGAL Clinical Trial of GPS in Acute Myeloid Leukemia (AML) – – Update on […]
Autonomix Appoints Jennifer Cook as Chief Business Officer
Proven executive with 28 years of success building winning B2C & B2B businesses, brands, and teams for premier consumer, healthcare, […]
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage […]
